rs137854609

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP5

The NM_001099404.2(SCN5A):​c.2989G>T​(p.Ala997Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000621 in 1,611,146 control chromosomes in the GnomAD database, with no homozygous occurrence. 15/24 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A997T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

SCN5A
NM_001099404.2 missense

Scores

3
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:5U:3O:1

Conservation

PhyloP100: -3.52

Publications

25 publications found
Variant links:
Genes affected
SCN5A (HGNC:10593): (sodium voltage-gated channel alpha subunit 5) The protein encoded by this gene is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. This protein is found primarily in cardiac muscle and is responsible for the initial upstroke of the action potential in an electrocardiogram. Defects in this gene have been associated with long QT syndrome type 3 (LQT3), atrial fibrillation, cardiomyopathy, and Brugada syndrome 1, all autosomal dominant cardiac diseases. Alternative splicing results in several transcript variants encoding different isoforms. [provided by RefSeq, May 2022]
SCN5A Gene-Disease associations (from GenCC):
  • Brugada syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Brugada syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Laboratory for Molecular Medicine, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • dilated cardiomyopathy 1E
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • sick sinus syndrome 1
    Inheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • progressive familial heart block, type 1A
    Inheritance: SD, AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp
  • atrial standstill
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial sick sinus syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • paroxysmal familial ventricular fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • progressive familial heart block
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PP5
Variant 3-38581170-C-A is Pathogenic according to our data. Variant chr3-38581170-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 9388.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001099404.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN5A
NM_001099404.2
MANE Plus Clinical
c.2989G>Tp.Ala997Ser
missense
Exon 17 of 28NP_001092874.1
SCN5A
NM_000335.5
MANE Select
c.2989G>Tp.Ala997Ser
missense
Exon 17 of 28NP_000326.2
SCN5A
NM_198056.3
c.2989G>Tp.Ala997Ser
missense
Exon 17 of 28NP_932173.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN5A
ENST00000413689.6
TSL:5 MANE Plus Clinical
c.2989G>Tp.Ala997Ser
missense
Exon 17 of 28ENSP00000410257.1
SCN5A
ENST00000423572.7
TSL:1 MANE Select
c.2989G>Tp.Ala997Ser
missense
Exon 17 of 28ENSP00000398266.2
SCN5A
ENST00000333535.9
TSL:1
c.2989G>Tp.Ala997Ser
missense
Exon 17 of 28ENSP00000328968.4

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152018
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
239824
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000480
AC:
7
AN:
1459128
Hom.:
0
Cov.:
36
AF XY:
0.00000551
AC XY:
4
AN XY:
725728
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33466
American (AMR)
AF:
0.00
AC:
0
AN:
44418
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26048
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39636
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85970
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52838
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5758
European-Non Finnish (NFE)
AF:
0.00000630
AC:
7
AN:
1110774
Other (OTH)
AF:
0.00
AC:
0
AN:
60220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152018
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74260
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41392
American (AMR)
AF:
0.00
AC:
0
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
67992
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000227

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:5Uncertain:3Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Pathogenic:1Uncertain:1
Aug 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 997 of the SCN5A protein (p.Ala997Ser). This variant is present in population databases (rs137854609, gnomAD 0.0008%). This missense change has been observed in individual(s) with clinical features of SCN5A-related conditions (PMID: 11710892, 18378609, 19716085). ClinVar contains an entry for this variant (Variation ID: 9388). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change affects SCN5A function (PMID: 11710892). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Sep 19, 2011
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The Ala997Ser mutation in the SCN5A gene was first reported by Ackerman et al. in a Caucasian male infant from a cohort of 93 possible Sudden Infant Death Syndrome (SIDS) cases, and was absent from 800 control alleles (Ackerman et al 2001). Ackerman et al. also reported that Ala997Ser showed an altered pattern of sodium current. Ala997Ser was also reported by Darbar et al. in a single patient with atrial fibrillation, but was also present in one out of 720 control alleles (Darbar et al 2008). Finally, Kapplinger et al. reported Ala997Ser in a single individual referred for LQTS testing, and was absent from at least 2,600 control alleles from individuals of various ethnic backgrounds (Kapplinger et al 2009). Located in the highly conserved DII-DIII intracellular domain linker region of SCN5A, Ala997Ser represents a non-conservative amino acid substitution of a non-polar Alanine residue with a polar Serine residue. Furthermore, a mutation in the same codon (Ala997Thr) has been reported in association with Brugada syndrome, further supporting the functional significance of this region of the protein. The variant is found in LQT panel(s).

Cardiac arrhythmia Uncertain:2
Dec 18, 2023
All of Us Research Program, National Institutes of Health
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This missense variant replaces alanine with serine at codon 997 of the SCN5A protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). Functional studies suggest a possible impact of this variant on sodium channel activity, however the clinical relevance of this observation is not known (PMID: 11710892). This variant has been reported in 1 individual with suspected long QT syndrome (PMID: 19716085), in 2 individuals with sudden death (PMID: 11710892, 29544605), and in 1 individual with atrial fibrillation (PMID: 18378609). This variant has been identified in 1/271150 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

Apr 27, 2023
Color Diagnostics, LLC DBA Color Health
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This missense variant replaces alanine with serine at codon 997 of the SCN5A protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). Functional studies suggest a possible impact of this variant on sodium channel activity, however the clinical relevance of this observation is not known (PMID: 11710892). This variant has been reported in 1 individual with suspected long QT syndrome (PMID: 19716085), in 2 individuals with sudden death (PMID: 11710892, 29544605), and in 1 individual with atrial fibrillation (PMID: 18378609). This variant has been identified in 1/271150 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

Dilated cardiomyopathy 1E;C1859062:Long QT syndrome 3;C3151464:Atrial fibrillation, familial, 10;C4551804:Brugada syndrome 1 Pathogenic:1
Dec 23, 2024
Clinical Genomics Laboratory, Washington University in St. Louis
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The SCN5A c.2989G>T (p.Ala997Ser) variant has been reported in at least three individuals affected with sudden infant death syndrome, atrial fibrillation, and long QT syndrome (Ackerman MJ et al., PMID: 11710892; Darbar D et al., PMID: 18378609; Kapplinger JD et al., PMID: 19716085). This variant is only observed on 1/271,150 alleles in the general population (gnomAD v.2.1.1), indicating it is not a common variant. Functional studies show that this variant results in slower decay with a 2-3 fold increase in late sodium current, indicating that this variant impacts protein function (Ackerman MJ et al., PMID: 11710892). Computational predictors are uncertain as to the impact of this variant on SCN5A function. Other variants in the same codon, c.2990C>A (p.Ala997Asp) and c.2989G>A (p.Ala997Thr), have been reported in individuals with sudden death syndromes (Wang D et al., PMID: 24631775; Ciconte G et al., PMID: 33221895) and are considered variants of uncertain significance; ClinVar Variation IDs: 67771, 165149). This variant has been reported in the ClinVar database as a germline pathogenic or likely pathogenic variant by three submitters and a variant of uncertain significance by three submitters. Based on available information and the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), this variant is classified as likely pathogenic.

SCN5A-related disorder Pathogenic:1
Sep 16, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The SCN5A c.2989G>T variant is predicted to result in the amino acid substitution p.Ala997Ser. This variant has been reported in multiple cohorts of sudden infant death syndrome and in a patient with a long QT syndrome phenotype (Ackerman et al. 2001. PubMed ID: 11710892; Kapplinger et al. 2009. PubMed ID: 19716085; Tester et al. 2018. PubMed ID: 29544605). This variant is reported in 0.00081% of alleles in individuals of European (non-Finnish) descent in gnomAD. An in vitro experimental study suggests this variant may disrupt sodium currents (Ackerman et al. 2001. PubMed ID: 11710892). Alternate missense substitutions affecting the same amino acid (p.Ala997Asp and p.Ala997Thr) have been reported in multiple cohorts of sudden death syndromes (Wang et al. 2014. PubMed ID: 24631775; Ciconte et al. 2021. PubMed ID: 33221895). Taken together, the c.2989G>T (p.Ala997Ser) variant is interpreted as likely pathogenic.

SUDDEN INFANT DEATH SYNDROME;C1832680:Dilated cardiomyopathy 1E;C1837845:Sick sinus syndrome 1;C1859062:Long QT syndrome 3;C1879286:Progressive familial heart block, type 1A;C2751898:Ventricular fibrillation, paroxysmal familial, type 1;C3151464:Atrial fibrillation, familial, 10;C4551804:Brugada syndrome 1 Pathogenic:1
Feb 15, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Long QT syndrome 3 Pathogenic:1
Nov 14, 2001
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Congenital long QT syndrome Other:1
Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

This variant has been reported as associated with Long QT syndrome in the following publications (PMID:11710892;PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
CardioboostArm
Benign
0.0000065
CardioboostCm
Benign
0.0017
BayesDel_addAF
Uncertain
0.023
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
0.0030
DANN
Benign
0.34
DEOGEN2
Benign
0.38
T
Eigen
Benign
-2.1
Eigen_PC
Benign
-2.3
FATHMM_MKL
Benign
0.089
N
LIST_S2
Benign
0.74
T
M_CAP
Benign
0.080
D
MetaRNN
Uncertain
0.65
D
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
0.0
N
PhyloP100
-3.5
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.42
N
REVEL
Uncertain
0.49
Sift
Benign
0.57
T
Sift4G
Benign
0.83
T
Polyphen
0.0010
B
Vest4
0.68
MutPred
0.78
Gain of glycosylation at A997 (P = 0.038)
MVP
0.99
MPC
0.028
ClinPred
0.037
T
GERP RS
-11
Varity_R
0.040
gMVP
0.44
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137854609; hg19: chr3-38622661; COSMIC: COSV61119231; API